Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion. | Neuroscience;212: 180-9, 2012 Jun 14. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.

Suofu, Y; Clark, J F; Broderick, J P; Kurosawa, Y; Wagner, K R; Lu, A.

Affiliation

Suofu Y; Department of Neurology, University of Cincinnati, Cincinnati, OH 45267-0532, USA.

Neuroscience ; 212: 180-9, 2012 Jun 14.

Article in En | MEDLINE | ID: mdl-22521821

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reperfusion Injury / Cerebral Hemorrhage / Brain Ischemia / Matrix Metalloproteinase 2 / Matrix Metalloproteinase 9 Limits: Animals Language: En Journal: Neuroscience Year: 2012 Document type: Article Affiliation country: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reperfusion Injury / Cerebral Hemorrhage / Brain Ischemia / Matrix Metalloproteinase 2 / Matrix Metalloproteinase 9 Limits: Animals Language: En Journal: Neuroscience Year: 2012 Document type: Article Affiliation country: Estados Unidos